WebMark Timney. Age : 56. Public asset : 14,158 USD. Country of residence : Unknown. Linked companies : Sarissa Capital Acquisition Corp. Biography of Mark Timney. Currently, Mark Timney is Chairman at Blade Therapeutics, Inc. and Chief Executive Officer & Director at The Medicines Co. Mr. Timney is also on the board of Biotechnology Innovation ... WebNov 8, 2024 · Blade Therapeutics Inc. would get $230 million via the special purpose acquisition company, or SPAC, sponsored by SPRIM Global Investments and another $24.3 million in private investment in public ...
Blade Therapeutics Revolutionizing the Treatment of Fibrotic …
WebPrior to LetsGetChecked, he was the Chief Financial Officer of Blade Therapeutics, Inc., a privately held biotechnology company. Mr. Maynard has served in various executive roles at Rigel Pharmaceuticals, Inc., a public commercial-stage drug development company, including 10 years as Chief Financial Officer. WebJun 25, 2024 · Blade Therapeutics: ClinicalTrials.gov Identifier: NCT04939467 Other Study ID Numbers: B-0409-104 : First Posted: June 25, 2024 Key Record Dates: Last Update Posted: April 15, 2024 Last Verified: April 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No: Layout table for additional information ... makeup to cover dark upper lip
About Leadership Investors Blade Therapeutics
WebDec 15, 2024 · Wendye Robbins, former Blade Therapeutics CEO. December 15, 2024 10:03 AM EST. Deals. Scoop: Blade Therapeutics CEO, CFO appear to depart amid 'transition' after nixed SPAC. WebOct 14, 2024 · Blade Therapeutics, Inc. is a biopharmaceutical company focused on developing cutting-edge treatments for debilitating, incurable fibrotic and neurodegenerative diseases that impact millions of ... WebApr 12, 2024 · Blade Air Mobility, Inc. (NASDAQ:BLDE – Get Rating) CFO William A. Heyburn sold 19,159 shares of Blade Air Mobility stock in a transaction dated Monday, April 10th. The stock was sold at an ... makeup to cover flushing